Home » Healthcare » Pharmaceuticals » Paranasal Sinus Cancer Market

Paranasal Sinus Cancer Market By Diagnosis (Medical history and physical examination, Imaging tests, Biopsy, Others) By Treatment (Surgery, Radiotherapy, Chemotherapy) By End User (Hospital & Clinics, Cancer Treatment & Research Center, Research Laboratories, Others)- Growth, Future Prospects, and Competitive Analysis, 2016 – 2028

Price: $4999

Published: | Report ID: 8562 | Report Format : PDF

About this report

The global Paranasal Sinus Cancer Market report explores the critical analysis of the paranasal sinus cancer industry using key parameters. The report consists of investment strategies, the need for investments in the paranasal sinus cancer industry, and the multiple benefits for the investors. Importantly, this report sets out major changes in the global technical regulations for the paranasal sinus cancer industry, as well as how economic and non-economic barriers are helping the paranasal sinus cancer market. Moreover, the report analyses the global, regional, and country-level historic and forecasted market size. The report also provides a comprehensive analysis of key investment propositions, demand and supply gap, competitors positioning, STAR analysis, SRC analysis, and Tornado analysis. Key technological developments and other analyses such as porter’s five forces analysis, PESTEL analysis, value chain analysis, etc.

 

Paranasal Sinus Cancer Market

Key Highlights of the report

How are the major segments performing in the Paranasal Sinus Cancer Market?

  • In 2021, imaging tests will be the leading segment. It is highly useful for examining malignancies of the paranasal sinuses and nasal cavities. They can distinguish between a fluid change and a malignancy.
  • In 2021, the surgery segment in the drug type will lead the market. The surgery removes the tumor. Cancer will also be removed if it has spread to the lymph nodes.
  • In 2021, the Hospital & Clinics segment in the end-user industry will lead the market. The category is expected to increase quickly during the projection due to rising disposable income and health concerns. 
Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Which region dominated the Paranasal Sinus Cancer Market?

In 2021, North America was one of the major contributors to the global paranasal sinus cancer market. The region’s market is developing as a result of the region’s well-established healthcare industry, rising healthcare expenditures, and rising rates of this rare type of cancer. Regional market expansion is also facilitated by cutting-edge technology and the presence of large competitors. A sophisticated healthcare sector and expanding government healthcare efforts contribute to the market’s growth.

What is the competitive environment of the Paranasal Sinus Cancer Market?

Many market participants currently control the worldwide paranasal sinus cancer market. Major companies are launching new products and forming strategic alliances to increase their market position. Rising company cooperation with research institutes is projected to generate growth opportunities for manufacturers in the near future. For instance, in January 2018, G.E. Healthcare established a long-term strategic collaboration with Roche Diagnostics to co-develop and sell digital clinical decision support technologies.

Executive Summary

What are the different signs of paranasal sinus cancer?

One of the rare cancers is paranasal sinus carcinoma. The open regions behind the nose, known as sinuses, are home to cancerous growths called paranasal sinus tumors. Major signs and symptoms include nasal blockage and congestion; purulent rhinorrhea; facial pain or pressure; headaches; and fever. Another indicator and symptom are chronic sinus infections that do not resolve with antibiotic therapy. Loss of vision or bulging of one eye; teeth ache or numbness; teeth loosening; and a pain or lump within the nose that does not go away. The market is anticipated to develop during the projected period due to factors like an aging population, an increase in uncommon cancers, and technological advancements in cancer treatment. About 3% to 5% of all head and neck cancers in the U.S. are paranasal sinus and nasal cavity tumors, which are uncommon. People 55 years or older account for almost 4 out of 5 cases.

Which are the key investments by the players in the Paranasal Sinus Cancer Industry Market?

The main therapeutics firms invest extensively in research and development to create effective paranasal sinus cancer treatments with low or no adverse effects. The increasing penetration of the region’s major pharmaceutical companies and increased investments in developing advanced healthcare infrastructure are boosting the market’s growth. For instance, Eli Lilly purchased ARMO Biosciences for USD 1.6 billion to extend its cancer portfolio, which provided support for that portfolio.

Some of the major players in the paranasal sinus cancer market are AbbVie, Inc., Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Hoffmann-La Roche Ltd., Becton, Dickinson and Company, Novartis AG, Ipsen Biopharmaceuticals Inc., Thermo Fisher Scientific, Abbott, G E Healthcare, Agilent Technologies Inc., AstraZeneca, Boehringer Ingelheim International GmbH and Bayer AG.

What are the Major Driving Factors for the Paranasal Sinus Cancer Market?

The market is anticipated to increase due to several factors, including rising chronic illness rates, rare cancer prevalence, technological improvements, and an aging population. An important factor that can support the growth of the paranasal sinus cancer market is the introduction of new products. Additionally, favorable healthcare costs fuel the market’s expansion. The market is being stimulated by the increasing usage of telehealth platforms’ education and consulting services and the increasing penetration of telehealth platforms globally.

What are the Major Risks for the Paranasal Sinus Cancer Market?

Advanced therapies are expensive, making it difficult for people with low and intermediate income levels to use them. A significant barrier to the sale of manufacturers’ goods is the absence of healthcare insurance in developing and developing countries. But strict government regulations for product approval could impede market expansion during the evaluation period.

Which is the Key Treatment in the Paranasal Sinus Cancer Market?

In 2021, the surgery segment dominated the paranasal sinus cancer market. The most common treatment for paranasal sinus tumors is surgery. During surgery, get rid of as much of the tumor as possible. If the spread of cancer has impacted the lymph nodes, they will also be removed. The operation will be planned to preserve most of your face and its functions. Surgery can be challenging and involves a team of specialists, including maxillofacial surgeons, neurosurgeons, and otolaryngologists (ENT doctors or otorhinolaryngologists).

How is the Paranasal Sinus Cancer Market performing in regions?

In 2021, the global paranasal sinus cancer market was dominated by North America. The rising occurrence of this rare type of cancer, the region’s well-developed healthcare industry, and rising healthcare expenditure fuel regional market expansion. Furthermore, well-developed technology and major market competitors promote regional market growth. The market is expanding due to the well-developed healthcare industry and expanding government initiatives in the healthcare sector. The increased use of cancer therapies and substantial funding from various organizations have created profitable growth prospects for key market competitors. The region’s dominance is linked to the strategic presence of important firms in the United States and Canada.

Besides, the Asia-Pacific region is expected to grow significantly over the forecast period. The regional market is growing due to improving economic conditions and rising government support for the healthcare industry. Additionally, the already expanding markets of China and India will dominate the regional market because affordable treatments and medications are available to treat the ailment. Additionally, the size of the regional market is growing due to the large patient population suffering from paranasal sinus cancer. Additionally, it is anticipated that public and private groups’ funding for research and development and changes to healthcare reimbursement laws will promote market expansion in the APAC region.

What is the regulatory landscape for the Paranasal Sinus Cancer Market?

The market is developing as a result of the funding provided by the government for research and rising healthcare costs. The market is anticipated to grow rapidly over the projected period due to increased regulatory approvals and an increase in cases of all types of cancer. In the U.S., healthcare spending is high per person. The United States spends about 18% of its GDP on healthcare overall. Increasing healthcare spending enables easier access to diagnostic tools and cutting-edge, ground-breaking paranasal sinus cancer treatments.

What is the Market Size of Paranasal Sinus Cancer regarding value?

The Paranasal Sinus Cancer Market is anticipated to grow at a substantial CAGR of 4.90% in the upcoming years. The global paranasal sinus cancer industry was estimated to be worth USD xx billion in 2021 and was expected to be worth USD xx billion by 2028.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

What are the major players planning for the future of the Paranasal Sinus Cancer Market?

The development of different surgical procedures, radiation therapy, and chemotherapy is aided by manufacturers’ adoption of cutting-edge technology like artificial intelligence (A.I.) and data analytics. In the future, market players should benefit from growth opportunities due to increased production and higher quality.

Segmentation of Global Paranasal Sinus Cancer Market-

Global Paranasal Sinus Cancer Market – By Diagnosis

  • Medical history and physical examination
  • Imaging tests
  • Biopsy
  • Others

Global Paranasal Sinus Cancer Market – By Treatment

  • Surgery
  • Radiotherapy
  • Chemotherapy

Global Paranasal Sinus Cancer Market – By End User

  • Hospital & Clinics
  • Cancer Treatment & Research Center
  • Research Laboratories
  • Others

Global Paranasal Sinus Cancer Market – By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global Paranasal Sinus Cancer Market
2.2. Global Paranasal Sinus Cancer Market, By Diagnosis
2.3. Global Paranasal Sinus Cancer Market, By Treatment
2.4. Global Paranasal Sinus Cancer Market, By End User
2.5. Global Paranasal Sinus Cancer Market, By Region

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global Paranasal Sinus Cancer Market Value, 2016-2028, (US$ Bn)
3.2. Market Dynamics
3.2.1. Key Growth Trends
3.2.2. Market Drivers
3.2.3. Market Restraints
3.2.4. Market Opportunities
3.2.5. Major Industry Challenges
3.3. Attractive Investment Proposition,2021
3.3.1. Diagnosis
3.3.2. Treatment
3.3.3. End User
3.3.4. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Value Chain Analysis
4.4. Technology Analysis
4.5. Marketing Strategy Analysis
4.5.1. Direct Marketing
4.5.2. Indirect Marketing
4.5.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2021
5.1. Company market share of key players, 2021
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. COVID 19 Impact Analysis
6.1. Global Paranasal Sinus Cancer Market Pre Vs Post COVID 19, 2019 – 2028
6.2. Impact on Import & Export
6.3. Impact on Demand & Supply

7. Global Paranasal Sinus Cancer Market
7.1. Global Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028(US$ Bn)
7.1.1. Overview
7.1.2. Global Paranasal Sinus Cancer Market, By Diagnosis, 2021 vs 2028 (in%)
7.1.3. Global Paranasal Sinus Cancer Market, By Medical History and Physical Examination, 2016-2028 (US$ Bn)
7.1.4. Global Paranasal Sinus Cancer Market, By Imaging Tests, 2016-2028 (US$ Bn)
7.1.5. Global Paranasal Sinus Cancer Market, By Biopsy, 2016-2028 (US$ Bn)
7.1.6. Global Paranasal Sinus Cancer Market, By Others, 2016-2028 (US$ Bn)
7.2. Global Paranasal Sinus Cancer Market, by Treatment, 2016-2028(US$ Bn)
7.2.1. Overview
7.2.2. Global Paranasal Sinus Cancer Market, By Treatment, 2021 vs 2028 (in%)
7.2.3. Global Paranasal Sinus Cancer Market, By Surgery, 2016-2028 (US$ Bn)
7.2.4. Global Paranasal Sinus Cancer Market, By Radiotherapy, 2016-2028 (US$ Bn)
7.2.5. Global Paranasal Sinus Cancer Market, By Chemotherapy, 2016-2028 (US$ Bn)
7.3. Global Paranasal Sinus Cancer Market, by End User, 2016-2028(US$ Bn)
7.3.1. Overview
7.3.2. Global Paranasal Sinus Cancer Market, By End User, 2021 vs 2028 (in%)
7.3.3. Global Paranasal Sinus Cancer Market, By Hospital & Clinics, 2016-2028 (US$ Bn)
7.3.4. Global Paranasal Sinus Cancer Market, By Cancer Treatment & Research Center, 2016-2028 (US$ Bn)
7.3.5. Global Paranasal Sinus Cancer Market, By Research Laboratories, 2016-2028 (US$ Bn)
7.3.6. Global Paranasal Sinus Cancer Market, By Others, 2016-2028 (US$ Bn)

8. North America Paranasal Sinus Cancer Market Analysis
8.1. North America Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Paranasal Sinus Cancer Market, by Treatment, 2016-2028(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Paranasal Sinus Cancer Market, by End User, 2016-2028(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Paranasal Sinus Cancer Market, by Country, 2016-2028 (US$ Bn)
8.4.1. U.S.
8.4.1.1. U.S. Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.1.2. U.S. Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
8.4.1.3. U.S. Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
8.4.1.4. U.S. Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)
8.4.2. Canada
8.4.2.1. Canada Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.2.2. Canada Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
8.4.2.3. Canada Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
8.4.2.4. Canada Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)

9. Europe Paranasal Sinus Cancer Market Analysis
9.1. Europe Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Paranasal Sinus Cancer Market, by Treatment, 2016-2028(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Paranasal Sinus Cancer Market, by End User, 2016-2028(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Paranasal Sinus Cancer Market, by Country, 2016-2028 (US$ Bn)
9.4.1. Germany
9.4.1.1. Germany Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.1.2. Germany Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
9.4.1.3. Germany Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
9.4.1.4. Germany Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)
9.4.2. France
9.4.2.1. France Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.2.2. France Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
9.4.2.3. France Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
9.4.2.4. France Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)
9.4.3. UK
9.4.3.1. UK Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.3.2. UK Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
9.4.3.3. UK Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
9.4.3.4. UK Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)
9.4.4. Italy
9.4.4.1. Italy Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.4.2. Italy Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
9.4.4.3. Italy Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
9.4.4.4. Italy Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)
9.4.5. Spain
9.4.5.1. Spain Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.5.2. Spain Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
9.4.5.3. Spain Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
9.4.5.4. Spain Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)
9.4.6. Rest of Europe
9.4.6.1. Rest of Europe Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.6.2. Rest of Europe Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
9.4.6.3. Rest of Europe Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
9.4.6.4. Rest of Europe Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)

10. Asia Pacific Paranasal Sinus Cancer Market Analysis
10.1. Asia Pacific Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Paranasal Sinus Cancer Market, by Treatment, 2016-2028(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Paranasal Sinus Cancer Market, by End User, 2016-2028(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Paranasal Sinus Cancer Market, by Country, 2016-2028 (US$ Bn)
10.4.1. China
10.4.1.1. China Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.1.2. China Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
10.4.1.3. China Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
10.4.1.4. China Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)
10.4.2. Japan
10.4.2.1. Japan Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.2.2. Japan Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
10.4.2.3. Japan Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
10.4.2.4. Japan Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)
10.4.3. India
10.4.3.1. India Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.3.2. India Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
10.4.3.3. India Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
10.4.3.4. India Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)
10.4.4. South Korea
10.4.4.1. South Korea Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.4.2. South Korea Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
10.4.4.3. South Korea Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
10.4.4.4. South Korea Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)
10.4.5. South-East Asia
10.4.5.1. South-East Asia Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.5.2. South-East Asia Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
10.4.5.3. South-East Asia Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
10.4.5.4. South-East Asia Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)
10.4.6. Rest of Asia Pacific
10.4.6.1. Rest of Asia Pacific Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.6.2. Rest of Asia Pacific Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
10.4.6.3. Rest of Asia Pacific Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
10.4.6.4. Rest of Asia Pacific Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)

11. Latin America Paranasal Sinus Cancer Market Analysis
11.1. Latin America Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Paranasal Sinus Cancer Market, by Treatment, 2016-2028(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Paranasal Sinus Cancer Market, by End User, 2016-2028(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Paranasal Sinus Cancer Market, by Country, 2016-2028 (US$ Bn)
11.4.1. Brazil
11.4.1.1. Brazil Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.1.2. Brazil Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
11.4.1.3. Brazil Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
11.4.1.4. Brazil Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)
11.4.2. Mexico
11.4.2.1. Mexico Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.2.2. Mexico Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
11.4.2.3. Mexico Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
11.4.2.4. Mexico Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)
11.4.3. Rest of Latin America
11.4.3.1. Rest of Latin America Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.3.2. Rest of Latin America Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
11.4.3.3. Rest of Latin America Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
11.4.3.4. Rest of Latin America Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)

12. Middle East and Africa Paranasal Sinus Cancer Market Analysis
12.1. Middle East and Africa Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Paranasal Sinus Cancer Market, by Treatment, 2016-2028(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Paranasal Sinus Cancer Market, by End User, 2016-2028(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Paranasal Sinus Cancer Market, by Country, 2016-2028 (US$ Bn)
12.4.1. GCC Countries
12.4.1.1. GCC Countries il Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.1.2. GCC Countries Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
12.4.1.3. GCC Countries Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
12.4.1.4. GCC Countries Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)
12.4.2. South Africa
12.4.2.1. South Africa Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.2.2. South Africa Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
12.4.2.3. South Africa Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
12.4.2.4. South Africa Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)
12.4.3. Rest of Middle East and Africa
12.4.3.1. Rest of Middle East and Africa Paranasal Sinus Cancer Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.3.2. Rest of Middle East and Africa Paranasal Sinus Cancer, By Diagnosis, 2016-2028 (US$ Bn)
12.4.3.3. Rest of Middle East and Africa Paranasal Sinus Cancer, By Treatment, 2016-2028 (US$ Bn)
12.4.3.4. Rest of Middle East and Africa Paranasal Sinus Cancer, By End User, 2016-2028 (US$ Bn)

13. Company Profiles
13.1. AbbVie, Inc.
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2021)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Pfizer Inc.
13.3. Eli Lily and Company
13.4. Bristol-Myers Squibb Company
13.5. Hoffman-La Roche Ltd.
13.6. Becton, Dickinson and Company
13.7. Novartis AG
13.8. Ipsen Biopharmaceuticals Inc.
13.9. Thermo Fisher Scientific
13.10. Abbott
13.11. G E Healthcare
13.12. Agilent Technologies Inc.
13.13. AstraZeneca
13.14. Boehringer Ingelheim International GmbH
13.15. Bayer AG

 

List of Figures

FIG. 1 Global Paranasal Sinus Cancer Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Paranasal Sinus Cancer Market Segmentation
FIG. 4 Global Paranasal Sinus Cancer Market, by Diagnosis, 2021 (US$ Bn)
FIG. 5 Global Paranasal Sinus Cancer Market, by Treatment, 2021 (US$ Bn)
FIG. 6 Global Paranasal Sinus Cancer Market, by End User, 2021 (US$ Bn)
FIG. 7 Global Paranasal Sinus Cancer Market, by Geography, 2021 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Diagnosis, 2021
FIG. 9 Attractive Investment Proposition, by Treatment, 2021
FIG. 10 Attractive Investment Proposition, by End User, 2021
FIG. 11 Attractive Investment Proposition, by Geography, 2021
FIG. 12 Global Market Share Analysis of Key Paranasal Sinus Cancer Market Manufacturers, 2021
FIG. 13 Global Market Positioning of Key Paranasal Sinus Cancer Market Manufacturers, 2021
FIG. 14 Global Paranasal Sinus Cancer Market Value Contribution, By Diagnosis, 2021 & 2028 (Value %)
FIG. 15 Global Paranasal Sinus Cancer Market, by Medical History and Physical Examination, Value, 2016-2028 (US$ Bn)
FIG. 16 Global Paranasal Sinus Cancer Market, by Imaging Tests, Value, 2016-2028 (US$ Bn)
FIG. 17 Global Paranasal Sinus Cancer Market, by Biopsy, Value, 2016-2028 (US$ Bn)
FIG. 18 Global Paranasal Sinus Cancer Market, by Others, Value, 2016-2028 (US$ Bn)
FIG. 19 Global Paranasal Sinus Cancer Market Value Contribution, By Treatment, 2021 & 2028 (Value %)
FIG. 20 Global Paranasal Sinus Cancer Market, by Surgery, Value, 2016-2028 (US$ Bn)
FIG. 21 Global Paranasal Sinus Cancer Market, by Radiotherapy, Value, 2016-2028 (US$ Bn)
FIG. 22 Global Paranasal Sinus Cancer Market, by Chemotherapy, Value, 2016-2028 (US$ Bn)
FIG. 23 Global Paranasal Sinus Cancer Market Value Contribution, By End User, 2021 & 2028 (Value %)
FIG. 24 Global Paranasal Sinus Cancer Market, by Hospital & Clinics, Value, 2016-2028 (US$ Bn)
FIG. 25 Global Paranasal Sinus Cancer Market, by Cancer Treatment & Research Center, Value, 2016-2028 (US$ Bn)
FIG. 26 Global Paranasal Sinus Cancer Market, by Research Laboratories, Value, 2016-2028 (US$ Bn)
FIG. 27 Global Paranasal Sinus Cancer Market, by Others, Value, 2016-2028 (US$ Bn)
FIG. 28 U.S. Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 29 Canada Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 30 Germany Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 31 France Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 32 U.K. Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 33 Italy Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 34 Spain Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 35 Rest of Europe Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 36 China Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 37 Japan Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 38 India Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 39 South Korea Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 40 Southeast Asia Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 41 Rest of Asia Pacific Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 42 Latin America Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 43 Brazil Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 44 Mexico Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 45 Rest of Latin America Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 46 Middle East & Africa Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 47 GCC Countries Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 48 South Africa Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)
FIG. 49 Rest of Middle East and Africa Paranasal Sinus Cancer Market, 2016-2028 (US$ Bn)

List of Tables

TABLE 1 Market Snapshot: Global Paranasal Sinus Cancer Market
TABLE 2 Global Paranasal Sinus Cancer Market, by Competitive Benchmarking, 2021
TABLE 3 Global Paranasal Sinus Cancer Market, by Geographical Presence Analysis, 2021
TABLE 4 Global Paranasal Sinus Cancer Market, by Key Strategies Analysis, 2021
TABLE 5 Global Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 6 Global Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 7 Global Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 8 Global Paranasal Sinus Cancer Market, by Geography, 2016-2028 (US$ Bn)
TABLE 9 North America Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 10 North America Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 11 North America Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 12 North America Paranasal Sinus Cancer Market, by Country, 2016-2028 (US$ Bn)
TABLE 13 US Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 14 US Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 15 US Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 16 Canada Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 17 Canada Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 18 Canada Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 19 Europe Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 20 Europe Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 21 Europe Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 22 Europe Paranasal Sinus Cancer Market, by Country, 2016-2028 (US$ Bn)
TABLE 23 Germany Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 24 Germany Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 25 Germany Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 26 France Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 27 France Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 28 France Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 29 UK Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 30 UK Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 31 UK Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 32 Italy Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 33 Italy Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 34 Italy Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 35 Spain Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 36 Spain Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 37 Spain Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 38 Rest of Europe Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 39 Rest of Europe Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 40 Rest of Europe Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 41 Asia Pacific Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 42 Asia Pacific Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 43 Asia Pacific Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 44 Asia Pacific Paranasal Sinus Cancer Market, by Country, 2016-2028 (US$ Bn)
TABLE 45 China Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 46 China Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 47 China Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 48 Japan Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 49 Japan Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 50 Japan Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 51 India Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 52 India Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 53 India Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 54 South Korea Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 55 South Korea Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 56 South Korea Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 57 South East Asia Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 58 South East Asia Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 59 South East Asia Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 60 Rest of Asia Pacific Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 61 Rest of Asia Pacific Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 62 Rest of Asia Pacific Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 63 Latin America Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 64 Latin America Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 65 Latin America Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 66 Latin America Paranasal Sinus Cancer Market, by Country, 2016-2028 (US$ Bn)
TABLE 67 Brazil Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 68 Brazil Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 69 Brazil Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 70 Mexico Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 71 Mexico Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 72 Mexico Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 73 Rest of Latin America Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 74 Rest of Latin America Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 75 Rest of Latin America Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 76 Middle East and Africa Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 77 Middle East and Africa Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 78 Middle East and Africa Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 79 Middle East and Africa Paranasal Sinus Cancer Market, by Country, 2016-2028 (US$ Bn)
TABLE 80 GCC Countries Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 81 GCC Countries Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 82 GCC Countries Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 83 South Africa Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 84 South Africa Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 85 South Africa Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)
TABLE 86 Rest of Middle East and Africa Paranasal Sinus Cancer Market, by Diagnosis, 2016-2028 (US$ Bn)
TABLE 87 Rest of Middle East and Africa Paranasal Sinus Cancer Market, by Treatment, 2016-2028 (US$ Bn)
TABLE 88 Rest of Middle East and Africa Paranasal Sinus Cancer Market, by End User, 2016-2028 (US$ Bn)

Frequently Asked Questions:

How does COVID-19 Impact the global Paranasal Sinus Cancer market?

The global Paranasal Sinus Cancer market is expected to be impacted significantly by COVID-19.

Which is the leading market for Paranasal Sinus Cancers?

North America accounted for the highest share in the global Paranasal Sinus Cancer market in terms of value.

What are the critical drivers for the growth of the Paranasal Sinus Cancer market?

The market is anticipated to increase due to several factors, including rising chronic illness rates, rare cancer prevalence, technological improvements, and an aging population.

Which is the primary diagnosis segment in Paranasal Sinus Cancer Market?

The imaging tests segment had a significant share in 2021, with more than 30% of the market revenue share.

Which is the primary treatment segment in Paranasal Sinus Cancer Market?

Surgery segment had a significant share in 2021, with more than 40% of the market revenue share.

U.S. 503b Compounding Pharmacies Market

Published:
Report ID: 15988

Inulin Market

Published:
Report ID: 11192

Drug Discovery Market

Published:
Report ID: 38270

Neurotrophic Keratitis Treatment Market

Published:
Report ID: 33425

Japan’s Pharmacy Automation Market

Published:
Report ID: 37511

Sterile Active Pharmaceutical Ingredient Market

Published:
Report ID: 37476

Organ Preservation Solutions Market

Published:
Report ID: 37472

Middle East and Africa Veterinary Vaccines Market

Published:
Report ID: 37309

Asia Pacific Stem Cell Therapy Market

Published:
Report ID: 37280

US Active Pharmaceutical Ingredient (API) Market

Published:
Report ID: 37221

Cancer Supportive Care Market

Published:
Report ID: 1901

Middle East and Africa Radiopharmaceuticals Market

Published:
Report ID: 37164

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN